cblz7k | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Patoulias%2C_Dimitrios%3B_Papadopoulos%2C_Christodoulos%3B_Katsimardou%2C_Alexandra%3B_Toumpourleka%2C_Maria%3B_Doumas%2C_Michael>
?:doi	10.1007/s13300-020-00942-7
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s13300-020-00942-7>
?:journal	Diabetes_Ther
?:license	cc-by-nc
?:pdf_json_files	document_parses/pdf_json/4504a2afcc65f921f29e6edf26faf4c979e6859d.json
?:pmc_json_files	document_parses/pmc_json/PMC7556544.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7556544>
?:pmid	<https://research.tib.eu/covid-19/entity/33052538.0>
?:pmid	33052538.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/4504a2afcc65f921f29e6edf26faf4c979e6859d>
?:source	Medline; PMC
?:title	Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-14

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/56cblz7k>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/56cblz7k>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all